BioCentury
ARTICLE | Finance

Solving for Y

Why Y Combinator decided to start investing in biotech

May 5, 2014 7:00 AM UTC

Start-up accelerator Y Combinator believes the capital needs for biotech formation have gone down. As a result, it is getting into a space it has traditionally avoided.

The accelerator, which has focused on digital tech since its founding in 2005, provides $120,000 in seed funding to early stage companies in exchange for a 7% stake...